PERSPECTA

News from every angle

Back to headlines

NTHI's Nasdaq Advantage After Breakthrough Phase 2a Results

NTHI's position on Nasdaq gains new significance following the announcement of its breakthrough Phase 2a clinical trial results.

17 Aug, 12:45 — 17 Aug, 12:45
PostShare